SERP1 and familial pancreatic carcinoma: This study demonstrated that myxomaviral protein Serp-1 inhibits growth of two different pancreatic cancer cell lines in NOD/SCID mice, providing a proof-of-concept that viral anti-inflammatory protein Serp-1 has the potential to be used for therapeutic application in treatment of pancreatic cancer.